Social Media for Epidemiology?

Epidemiologists consider how social media could be harnessed to predict disease outbreaks.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA COMMONS, ALTON

Epidemiologists are converging this Thursday (February 16) at the 2012 International Conference on Digital Disease Detection at Harvard Medical School in Boston, Massachusetts. On the agenda is informal media—like Twitter, blog posts, and web searches—and how these could be applied to identify, track, and predict disease outbreaks. The meeting is sponsored by the CDC and HealthMap, and run by a team of researchers at Children’s Hospital Boston, which mines online data to identify and track disease outbreaks.

Although informal media is already being utilized by researchers, such as Twitter to track cholera outbreaks in Haiti, not everyone is ready to incorporate it into their surveillance. Informal data’s reliability is yet untested, Andrea Dugas of Johns Hopkins Hospita in Baltimore told Nature. Informal data have also ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development